2v13: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
[[Image:2v13. | [[Image:2v13.png|left|200px]] | ||
<!-- | <!-- | ||
| Line 24: | Line 24: | ||
==Reference== | ==Reference== | ||
Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin., Rahuel J, Rasetti V, Maibaum J, Rueger H, Goschke R, Cohen NC, Stutz S, Cumin F, Fuhrer W, Wood JM, Grutter MG, Chem Biol. 2000 Jul;7(7):493-504. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10903938 10903938] | Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin., Rahuel J, Rasetti V, Maibaum J, Rueger H, Goschke R, Cohen NC, Stutz S, Cumin F, Fuhrer W, Wood JM, Grutter MG, Chem Biol. 2000 Jul;7(7):493-504. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10903938 10903938] | ||
The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor., Rahuel J, Priestle JP, Grutter MG, J Struct Biol. 1991 Dec;107(3):227-36. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/1807356 1807356] | |||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Renin]] | [[Category: Renin]] | ||
| Line 48: | Line 50: | ||
[[Category: Zymogen]] | [[Category: Zymogen]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 05:19:02 2008'' | ||
